Investment case
Biohaven Pharmaceutical Holding Company Ltd.
BHVN · 4 developments mapped · last assessed 2026-08-28
Market Ontology has mapped 4 macro, policy, and market developments to Biohaven Pharmaceutical Holding Company Ltd. since 2026-08-26. Each one is traced from the driver to the valuation assumption it moves, and the valuation below is run on the same engine the subscription uses.
Valuation
No validated run has been published for BHVN yet, so no modelled value is shown. The BHVN valuation is in the public catch-up queue.
Subscribers do not wait for the weekly cycle: they run BHVN on demand, against live prices and the latest filings, and change any assumption the developments below move.
Filed financials
Current case
- Strongest support
Biohaven partners with SK Biopharmaceuticals in $795M licensing deal
Direct financial injection and validation of pipeline asset.
· Moves probability of success for kv7 program, discount rate (due to reduced funding risk), future r&d spending capacity
What changed, by assumption
- 2026-08-28Biohaven partners with SK Biopharmaceuticals in $795M licensing deal
- 2026-08-28Biohaven Secures $795M Licensing Pact With SK Biopharmaceuticals for Opakalim
- 2026-08-28Biohaven Signs $795M Licensing Deal with SK Biopharm for Opakalim
- 2026-08-26SK Biopharmaceuticals Co., Ltd. to Acquire Biohaven Ltd. ($795M)
Assumption changes
Full ledger →| Date | Assumption | Direction | Why | Conf. |
|---|---|---|---|---|
| 2026-08-26 | Valuation multiple | Bullish | Target re-rates to bid premium until close. | 0.70 |
Event impact log
Full ledger →| Date | Mechanism | Direction | Horizon | Impact |
|---|---|---|---|---|
| 2026-08-28 | Biohaven partners with SK Biopharmaceuticals in $795M licensing deal | Bullish | 1-3m | 0.80 |
| 2026-08-28 | Biohaven Secures $795M Licensing Pact With SK Biopharmaceuticals for Opakalim | Bullish | 1-3m | 0.80 |
| 2026-08-28 | Biohaven Signs $795M Licensing Deal with SK Biopharm for Opakalim | Bullish | 1-3m | 0.80 |
| 2026-08-26 | SK Biopharmaceuticals Co., Ltd. to Acquire Biohaven Ltd. ($795M) | Bullish | 1-3m | 0.80 |